NELFCD and cancer: In this context, an ideal cancer vaccine should be, first, able to stimulate strong Th-1 response specifically (since Th-2 response may facilitate cancer progression and metastasis), and second, tumor-specific (inducing adaptive immunity specifically against cancer cells while sparing normal cells).